Indicated for: hyperphosphatemia
Route of administration: oral
Substance: sevelamer (phosphate binder)
ATC: V03AE02 (Various | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia)
Sevelamer is a medication used to control hyperphosphatemia in patients with chronic kidney disease on dialysis. It works by binding to dietary phosphates in the gastrointestinal tract, reducing their absorption and serum phosphate levels.
The medication is taken orally, as directed by a doctor, usually with meals. It is important for patients to follow the treatment regimen and adhere to a low-phosphate diet.
Patients should be aware of potential side effects, such as gastrointestinal disturbances, nausea, or constipation. It is important to inform the doctor of any unusual symptoms.
Common side effects include gastrointestinal disturbances, nausea, and constipation. In rare cases, severe reactions such as intestinal obstruction or gastrointestinal perforation may occur. Patients should be informed of these risks before starting treatment.